Is Empyrean Technology (SZSE:301269) A Risky Investment?
Is Empyrean Technology (SZSE:301269) A Risky Investment?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know worries about.' When we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to ruin. We can see that Empyrean Technology Co., Ltd. (SZSE:301269) does use debt in its business. But the more important question is: how much risk is that debt creating?
霍華德·馬克斯說得好,他說的不是擔心股價的波動,而是 “永久損失的可能性是我擔心的風險... 也是我認識的每位實際投資者所擔心的風險。”當我們思考一家公司的風險有多大時,我們總是喜歡考慮其債務的用途,因爲債務過載可能導致破產。我們可以看到,Empyrean科技股份有限公司(深圳證券交易所代碼:301269)確實在其業務中使用了債務。但更重要的問題是:這筆債務會帶來多大的風險?
What Risk Does Debt Bring?
債務會帶來什麼風險?
Generally speaking, debt only becomes a real problem when a company can't easily pay it off, either by raising capital or with its own cash flow. Ultimately, if the company can't fulfill its legal obligations to repay debt, shareholders could walk away with nothing. However, a more common (but still painful) scenario is that it has to raise new equity capital at a low price, thus permanently diluting shareholders. Of course, the upside of debt is that it often represents cheap capital, especially when it replaces dilution in a company with the ability to reinvest at high rates of return. When we think about a company's use of debt, we first look at cash and debt together.
一般而言,只有當公司無法通過籌集資金或用自己的現金流輕鬆還清債務時,債務才會成爲真正的問題。最終,如果公司無法履行償還債務的法律義務,股東們可能會一無所獲。但是,更常見(但仍然令人痛苦)的情況是,它必須以低廉的價格籌集新的股本,從而永久稀釋股東。當然,債務的好處在於它通常代表廉價資本,尤其是當它以高回報率進行再投資的能力取代公司的稀釋時。當我們考慮公司使用債務時,我們首先將現金和債務放在一起考慮。
View our latest analysis for Empyrean Technology
查看我們對 Empyrean Technology 的最新分析
What Is Empyrean Technology's Net Debt?
Empyrean Technology的淨負債是多少?
As you can see below, Empyrean Technology had CN¥117.2m of debt at September 2023, down from CN¥312.6m a year prior. However, it does have CN¥3.10b in cash offsetting this, leading to net cash of CN¥2.98b.
如下所示,截至2023年9月,Empyrean Technology的債務爲1.172億加元,低於去年同期的3.126億加元。但是,它確實有310億元人民幣的現金抵消了這一點,淨現金爲29.8億元人民幣。
How Strong Is Empyrean Technology's Balance Sheet?
Empyrean Technology的資產負債表有多強?
Zooming in on the latest balance sheet data, we can see that Empyrean Technology had liabilities of CN¥369.4m due within 12 months and liabilities of CN¥214.4m due beyond that. On the other hand, it had cash of CN¥3.10b and CN¥196.3m worth of receivables due within a year. So it actually has CN¥2.71b more liquid assets than total liabilities.
放大最新的資產負債表數據,我們可以看到,Empyrean Technology在12個月內到期的負債爲3.694億元人民幣,之後到期的負債爲2.144億元人民幣。另一方面,它有一年內到期的現金爲31.0億元人民幣和價值1.963億元人民幣的應收賬款。所以它實際上有271億元人民幣 更多 流動資產超過總負債。
This short term liquidity is a sign that Empyrean Technology could probably pay off its debt with ease, as its balance sheet is far from stretched. Simply put, the fact that Empyrean Technology has more cash than debt is arguably a good indication that it can manage its debt safely. There's no doubt that we learn most about debt from the balance sheet. But ultimately the future profitability of the business will decide if Empyrean Technology can strengthen its balance sheet over time. So if you're focused on the future you can check out this free report showing analyst profit forecasts.
這種短期流動性表明,Empyrean Technology可能會輕鬆償還債務,因爲其資產負債表遠未緊張。簡而言之,Empyrean Technology的現金多於債務這一事實可以說是一個很好的跡象,表明它可以安全地管理債務。毫無疑問,我們從資產負債表中學到的關於債務的知識最多。但最終,該業務未來的盈利能力將決定Empyrean Technology能否隨着時間的推移加強其資產負債表。因此,如果您專注於未來,可以查看這份顯示分析師利潤預測的免費報告。
Over 12 months, Empyrean Technology reported revenue of CN¥955m, which is a gain of 33%, although it did not report any earnings before interest and tax. Shareholders probably have their fingers crossed that it can grow its way to profits.
在過去的12個月中,Empyrean Technology公佈的收入爲9.55億元人民幣,增長了33%,儘管它沒有報告任何利息和稅前收益。股東們可能對它能夠實現盈利抱有疑慮。
So How Risky Is Empyrean Technology?
那麼 Empyrean 技術的風險有多大呢?
While Empyrean Technology lost money on an earnings before interest and tax (EBIT) level, it actually booked a paper profit of CN¥244m. So when you consider it has net cash, along with the statutory profit, the stock probably isn't as risky as it might seem, at least in the short term. Keeping in mind its 33% revenue growth over the last year, we think there's a decent chance the company is on track. There's no doubt fast top line growth can cure all manner of ills, for a stock. When analysing debt levels, the balance sheet is the obvious place to start. However, not all investment risk resides within the balance sheet - far from it. For instance, we've identified 1 warning sign for Empyrean Technology that you should be aware of.
儘管Empyrean Technology在息稅前收益(EBIT)水平上虧損,但其實際賬面利潤爲2.44億元人民幣。因此,當你考慮到它有淨現金和法定利潤時,該股票的風險可能沒有看起來那麼大,至少在短期內是如此。考慮到其去年收入增長了33%,我們認爲該公司很有可能步入正軌。毫無疑問,收入的快速增長可以治癒股票的各種弊病。在分析債務水平時,資產負債表是顯而易見的起點。但是,並非所有的投資風險都存在於資產負債表中,遠非如此。例如,我們已經確定了Empyrean Technology的1個警告信號,你應該注意這一點。
If, after all that, you're more interested in a fast growing company with a rock-solid balance sheet, then check out our list of net cash growth stocks without delay.
畢竟,如果你對一家資產負債表堅如磐石的快速成長型公司更感興趣,那麼請立即查看我們的淨現金增長股票清單。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。